Company News, Financial News

Merz Acquires Neocutis

Deal features company’s cosmetics, OTC and Rx skin care business.

Author Image

By: TOM BRANNA

Editor

Merz Pharma Group (Frankfurt am Main) has entered into a definitive agreement with Swiss dermatology company Neocutis S.A. to acquire the privately held company’s cosmetics, OTC, and Rx skin care business. The acquisition of Neocutis strengthens Merz’s market position in the field of aesthetics and reflects the Company’s strategy to establish itself as a global leader in medical and aesthetic dermatology. “Neocutis is an innovative company with an excellent presence in the US market, and a prom...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters